300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology Startup Investors in Norway (October 2026)

The most active venture capital funds and angel investors investing in Norway Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Norway Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Investinor
VC Fund
12 Norway, United States, Sweden Venture - Series Unknown, Series A Software, Biotechnology, Manufacturing $2M–$25M
Birk Venture
VC Fund
5 Norway, United Kingdom Seed, Series A Biotechnology, Medical, Health Care $1.2M–$20M
Hadean Ventures
VC Fund
4 Sweden, Norway, Austria Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $2M–$79M
Forbion Capital Partners
VC Fund
3 United States, United Kingdom, The Netherlands Series A, Series B, Series C Biotechnology, Health Care, Medical $16M–$180M
SINTEF Venture AS
VC Fund
3 Norway, United States, United Kingdom Seed, Venture - Series Unknown Manufacturing, Information Technology, Software $160k–$17M
Sarsia Seed Management
VC Fund
2 Norway Venture - Series Unknown, Seed Biotechnology, Software, Pharmaceutical $1.5M–$3.9M
Sandwater
VC Fund
2 Norway, Germany, Finland Series A, Venture - Series Unknown, Series B Manufacturing, Medical, AgTech $4.7M–$35M
Canica
VC Fund
2 Norway, Denmark, Singapore Series A, Private Equity, Venture - Series Unknown Biotechnology, Beauty, Retail $2.1M–$29M
Meneldor
VC Fund
2 Norway, Germany, United Kingdom Series A, Seed, Debt Financing Biotechnology, Health Care, Pharmaceutical $2.2M–$65M
Sarsia
VC Fund
2 Norway, Sweden, Finland Seed, Pre-Seed, Venture - Series Unknown Software, SaaS, Sensor $625k–$8.8M
Farvatn Venture
VC Fund
2 Norway, United States, United Kingdom Seed, Pre-Seed Software, Artificial Intelligence, Health Care $120k–$8M
BIF Partners
VC Fund
2 Germany, Israel, Norway Seed, Convertible Note, Pre-Seed Health Care, Biotechnology, Therapeutics $1.3M–$2M
M Ventures
VC Fund
2 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
EISMEA
VC Fund
2 Spain, Italy, United Kingdom Grant, Venture - Series Unknown, Seed Manufacturing, Software, Biotechnology $53k–$2.6M
The Index Project
VC Fund
1 United States, Denmark, Chile Seed, Series A, Series B Chemical, Artificial Intelligence, SaaS $1.1M–$3M
NantBio
VC Fund
1 Norway Seed Life Science, Biotechnology
DNB
VC Fund
1 Norway, Sweden, United States Post-IPO Debt, Debt Financing, Venture - Series Unknown Renewable Energy, Energy, Oil and Gas $240k–$1.5B
Faber
VC Fund
1 Portugal, Germany, United Kingdom Seed, Pre-Seed, Series A Software, Artificial Intelligence, SaaS $121k–$25M
Bakken & Baeck
VC Fund
1 Norway Seed, Angel Chemical, Software, Life Science
PAACS Invest AS
VC Fund
1 Norway Seed Consulting, Health Care, Biotechnology
Norselab
VC Fund
1 Norway, Switzerland, United States Seed, Venture - Series Unknown, Series A Software, SaaS, Agriculture $500k–$30M
Advent Life Sciences
VC Fund
1 United States, United Kingdom, France Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $5.5M–$104M
CoFounder
VC Fund
1 Norway Seed, Series A Industrial, Manufacturing, SaaS $956k–$2.3M
Fernando Lelo de Larrea H.
Angel
1 Mexico, United States, Spain Seed, Series A, Series B E-Commerce, Financial Services, FinTech $155k–$21M
Sofinnova Partners
VC Fund
1 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
Innovestor
VC Fund
1 Finland, Sweden, Denmark Seed, Pre-Seed Software, Health Care, Information Technology $204k–$4.5M
Arkin Bio Ventures
VC Fund
1 United States, Israel, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $11M–$182M
Lekh Corp AS
VC Fund
1 Norway Pre-Seed Software, Health Care, Life Science
Coalition for Epidemic Preparedness Innovations
VC Fund
1 United States, India, United Kingdom Grant, Post-IPO Equity, Seed Biotechnology, Health Care, Pharmaceutical $2.5M–$145M
4BIO Capital
VC Fund
1 United States, United Kingdom, France Series A, Seed, Series B Biotechnology, Health Care, Therapeutics $5M–$125M
Teknoinvest
VC Fund
1 Sweden, Norway, United States Series B, Series A Health Care, Biotechnology, Medical $1.2M–$31M
TeleVenture Management
VC Fund
1 Norway, United States Venture - Series Unknown, Seed Software, Manufacturing, Biotechnology $686k–$5.9M
Surveyor Capital
VC Fund
1 United States, China, Canada Series B, Post-IPO Equity, Series C Biotechnology, Health Care, Therapeutics $41M–$280M
Bioqube Ventures
VC Fund
1 United States, France, Norway Seed, Series A, Series B Biotechnology, Therapeutics, Life Science $4M–$108M
Innovations Kapital
VC Fund
1 Sweden, Denmark, United States Series B, Series C Biotechnology, Health Care, Software $5.5M–$30M
ERM Invest
VC Fund
1 Norway Pre-Seed Software, Health Care, Life Science
Norwegian Research Council
VC Fund
1 Norway, Sweden Grant, Seed, Venture - Series Unknown Health Care, Biotechnology, Information Technology $90k–$25M
TD Veen
VC Fund
1 Norway, United Kingdom, Germany Seed, Venture - Series Unknown Internet, Software, Information Technology $913k–$19M
Gezina
VC Fund
1 Norway Health Care, Biotechnology, Clinical Trials
HealthCap
VC Fund
1 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $6M–$92M
Qomel
VC Fund
1 Norway Seed Life Science, Biotechnology
Dynamk Capital
VC Fund
1 United States, Canada, Norway Series A, Seed, Series B Biotechnology, Medical, Health Care
Advent Venture Partners
VC Fund
1 United Kingdom, United States, Switzerland Series B, Series A Biotechnology, Health Care, Software $6.6M–$50M
Nordic Impact
VC Fund
1 Norway Seed Chemical, Life Science, Visual Search
Project Sandwater
VC Fund
1 Norway, The Netherlands Series A Medical, Consulting, Life Science $12M–$20M
SR One
VC Fund
1 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6M–$175M
H2O Holding AS
VC Fund
1 Norway Pre-Seed Software, Health Care, Life Science
Patrick Pichette
Angel
1 United Kingdom, Germany, United States Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $913k–$95M
World Wildlife Fund
VC Fund
1 Canada, Norway, Faroe Islands Seed, Series A Seafood, Aquaculture, Food Processing $1.5M–$6.2M
Protonic Partners
VC Fund
1 Norway Seed SaaS, Biometrics, Information Services
Access all 152 investors in Norway Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Investinor
VC Fund · Trondheim, Sor-Trondelag, Norway · 12 investments in Norway Biotechnology startups

Investinor invests in Norwegian based, high potential companies that are internationally oriented and in the phases ranging from early growth to expansion. The company has BNOK 4.2 ($500 m) under management and focus on companies within the internet, software, semiconductors, energy, cleantech, marine and life sciences sectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Venture - Series Unknown, Series A
  • Geography: Norway, United States, Sweden

Investor stats

  • Total investments: 133
  • Round size: Series A $2.3M–$25M; Venture - Series Unknown $2M–$19M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: May invest from a new fund soon — raised $274M in 2011

Portfolio highlights

  • Sonair — Sonair is building ADAR, the world's first safety-certified 3D sensor for human-robot collaboration. The commercial product is available now. Reach out for a demo.
  • Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
  • Muybridge — Reimagining cameras with weightless software-based viewpoint
Show all investments...

Birk Venture
VC Fund · Oslo, Oslo, Norway · 5 investments in Norway Biotechnology startups

Birk Venture is a Scandinavian venture company exclusively focusing on the life science industry.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Series A
  • Geography: Norway, United Kingdom

Investor stats

  • Total investments: 9
  • Round size: Seed $1.3M–$15M; Series A $1.2M–$20M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • APIM Therapeutics — APIM Therapeutics is based on an original discovery by Prof. Marit Otterlei and co-inventors at the Department of Cancer Research and Molecular Medicine at NTNU (Trondheim, Norway). The company is currently developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen), a key DNA repair protein regulating cellularresponses to DNA damage and stress.
  • Zelluna Immunotherapy — Zelluna Immunotherapy AS is a privately owned biopharmaceutical company focused on the development of TCR based immunotherapies.
  • Accession Therapeutics — Accession Therapeutics is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumor diversity. It is the first company to have engineered a viral point of entry to cancer cells while bypassing healthy cells - so it’s ‘gloves off’ in the fight against cancer." It was founded in 2020 and is locatedin Oxford, Oxfordshire, United Kingdom.
Show all investments...

Hadean Ventures
VC Fund · Oslo, Oslo, Norway · 4 investments in Norway Biotechnology startups

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across the region

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Sweden, Norway, Austria

Investor stats

  • Total investments: 36
  • Round size: Series A $4.2M–$79M; Series B $4.5M–$75M; Venture - Series Unknown $2M–$29M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — raised $168M in 2021

Portfolio highlights

  • Oncoinvent — Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
  • Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 3 investments in Norway Biotechnology startups

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 229
  • Round size: Series A $19M–$180M; Series B $16M–$155M; Series C $22M–$123M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely actively investing — fresh fund, raised $606M in 2026

Portfolio highlights

  • OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
  • Lisata Therapeutics — Lisata is a clinical-stage pharmaceutical company dedicated to improving lives through the discovery, development, and commercialization of innovative medicines.
Show all investments...

SINTEF Venture AS
VC Fund · Trondheim, Sor-Trondelag, Norway · 3 investments in Norway Biotechnology startups

We commercialize technology created by SINTEF's research environments

Show more...

Investment focus

  • Industry: Manufacturing, Information Technology, Software
  • Stage:Seed, Venture - Series Unknown
  • Geography: Norway, United States, United Kingdom

Investor stats

  • Total investments: 34
  • Round size: Seed $160k–$6.2M; Venture - Series Unknown $1.5M–$17M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $62M in 2018

Portfolio highlights

  • Sonair — Sonair is building ADAR, the world's first safety-certified 3D sensor for human-robot collaboration. The commercial product is available now. Reach out for a demo.
  • Hystar — Hystar develops polymer electrolyte membrane electrolyzers designed for large-scale green hydrogen production. Founded in 2020, Hystar's technology uses a unique cell design and process architecture that provides the ability to reduce electricity consumption and increase hydrogen output, enabling professionals to tackle various criticalenergy challenges and having the potential to reduce greenhouse gas emissions.
  • Hydrogen Mem-Tech — Hydrogen Mem-Tech aim is to make the green shift happen through our state-of-the-art hydrogen separation technology with carbon capture.
Show all investments...

Sarsia Seed Management
VC Fund · North Bergen, New Jersey, United States · 2 investments in Norway Biotechnology startups

Sarsia Seed AS is a Norwegian Seed Capital Fund which invests in Norwegian early phase technology companies within the energy/cleantech and biotechnology/life science sectors. The fund has a total capital of 333.5 million NOK (approx, 40 mEUR/50 mUSD) and is managed by Sarsia Seed Management AS. The management company advises the Fund board regarding investment decisions. The Fundâ€:tm:s duration is expected to be 12 (+3) years. The Management Teamâ€:tm:s strength lay in its competence, experience and extensive national and international network of industrial players and co-investors. The Teamâ€:tm:s collective experience comprises an optimal balance between operations, business and specialised technology know-how, applied research, and entrepreneurship; elements which are actively used both in the vetting and follow-up of investments.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Pharmaceutical
  • Stage:Venture - Series Unknown, Seed
  • Geography: Norway

Investor stats

  • Total investments: 11
  • Round size: Venture - Series Unknown $1.5M–$3.9M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • BerGenBio — BerGenBio is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers.
  • Sonoclear — At SonoClear, we are dedicated to improving the diagnostic accuracy of ultrasound to give neurosurgeons the clarity needed to make critical decisions in the resection of tumours.
  • Heimdall Power — Heimdall Power helps utilities optimize the power grid with state-of-the-art sensors and software, enabling real-time capacity management and situational awareness for a more efficient and reliable energy system.
Show all investments...

Sandwater
VC Fund · Oslo, Oslo, Norway · 2 investments in Norway Biotechnology startups

We are Sandwater. Regeneration of our resources. Vitalizing healthcare & education. Improving life through technology.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, AgTech
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: Norway, Germany, Finland

Investor stats

  • Total investments: 24
  • Round size: Series A $8.5M–$24M; Series B $17M–$35M; Venture - Series Unknown $4.7M–$18M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Mantle8 — Using bottom-up exploration and decades of geology experience, we are on a mission to deliver natural hydrogen to the world.
  • CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
  • Alva Industries — Serving industries from aerospace to marine, we deliver high-performance, sustainable motors to drive a cleaner, more efficient future.
Show all investments...

Canica
VC Fund · Oslo, Oslo, Norway · 2 investments in Norway Biotechnology startups

Canica is one of the largest privately owned investment companies in Norway. Our operations are focused on active, long-term ownership, primarily within sectors covering retail, fast moving consumer goods and real estate. Canica can offer core expertise within the fields of business development and finance, as well as capital and network in orderto create value and employment in a long-term perspective.

Show more...

Investment focus

  • Industry: Biotechnology, Beauty, Retail
  • Stage:Series A, Private Equity, Venture - Series Unknown
  • Geography: Norway, Denmark, Singapore

Investor stats

  • Total investments: 16
  • Round size: Series A $2.1M–$25M; Venture - Series Unknown $20M–$29M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Healthily — The path to perfect health starts with self-care and Healthily is here to guide you step by step.
  • Cytovation — Cytovation AS is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway.
  • Oncoinvent — Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
Show all investments...

Meneldor
VC Fund · Druten, Gelderland, The Netherlands · 2 investments in Norway Biotechnology startups

Meneldor is a Dutch life-sciences investment firm backing exceptional science with disciplined VC capital to build and scale European biopharma with real impact.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Seed, Debt Financing
  • Geography: Norway, Germany, United Kingdom

Investor stats

  • Total investments: 8
  • Round size: Series A $2.2M–$65M; Debt Financing $10M–$10M
  • Lead/follow: 88% lead, 12% follow

Portfolio highlights

  • Hemispherian — Hemispherian is an innovative preclinical pharmaceutical company focused on developing a novel class of small molecule drugs. These drugs target the TET2 enzyme as an epigenetic therapy for particularly aggressive cancers.
  • Atriva Therapeutics — Therapies against viral infections. First-in-class host-targeting therapies to treat respiratory viral infections, including COVID-19 and influenza.
  • Tagworks Pharmaceuticals — As pioneers of Click-to-Release technology, we are revolutionizing cancer treatment using in vivo click chemistry to increase the therapeutic window of powerful cancer therapies.
Show all investments...

Sarsia
VC Fund · Bergen, Hordaland, Norway · 2 investments in Norway Biotechnology startups

Sarsia is an early-stage venture capital investor that invest in science-based technology companies. It was founded in 2006 and is located in Bergen, Hordaland.

Show more...

Investment focus

  • Industry: Software, SaaS, Sensor
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Norway, Sweden, Finland

Investor stats

  • Total investments: 10
  • Round size: Seed $2.1M–$2.7M; Pre-Seed $625k–$4.3M; Venture - Series Unknown $3.8M–$8.8M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Cetasol — Maritime monitoring and analytics software for commercial fleets. Full visibility, fuel savings, and compliance support.
  • Birdsview — Sensor fusion of GPR radar, lidar and camera plus AI analysis: see inside any concrete structure without breaking it.
  • Mitigrate — Mitigrate is building a SaaS platform to predict how physical climate risk will impact property assets in the future. The system provides businesses and asset owners with a cost-effective strategy to mitigate risk. The user gets connected to certified, local adaptation specialists who refine and implement the solution.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Farvatn Venture
VC Fund · 2 investments in Norway Biotechnology startups

Planet 9 Venture supports startups and work with venture funds to make a positive imprint on the world.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: Norway, United States, United Kingdom

Investor stats

  • Total investments: 85
  • Round size: Seed $1M–$8M; Pre-Seed $120k–$1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Visoid — Render your 3D models with ease! Quick and easy rendering software for architects, powered by AI. Try Visoid for free!
  • BioSort — Biometrics provides lice, biomass, extraction, and data analysis. They offer feed, fish health, welfare, optimized harvest aquaculture, and fisheries. They provide sensor technologies, machine vision, AI, software, mechatronics.
  • Birdsview — Sensor fusion of GPR radar, lidar and camera plus AI analysis: see inside any concrete structure without breaking it.
Show all investments...

BIF Partners
VC Fund · Hamburg, Hamburg, Germany · 2 investments in Norway Biotechnology startups

Angel Investors focusing on Seed Investments

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: Germany, Israel, Norway

Investor stats

  • Total investments: 14
  • Round size: Seed $1.3M–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Hemispherian — Hemispherian is an innovative preclinical pharmaceutical company focused on developing a novel class of small molecule drugs. These drugs target the TET2 enzyme as an epigenetic therapy for particularly aggressive cancers.
  • ECO Group — Eco is a supplier of consumer products. They create structures for increased growth and profitability within the group companies.
  • Lucid Genomics — Lucid Genomics is an AI-powered platform that focuses on diagnostics and biomarker detection. It offer comprehensive DNA analysis, that includes coding and non-coding mutation prioritization and interpretation.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Norway Biotechnology startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 189
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$56M; Series B $13M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Mueon — semiconductor-based systems for AI and hyperscale computing
  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • Polaris Electro-Optics — Polaris Electro-Optics empowers integrated photonics for communications and computation.
Show all investments...

EISMEA
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Norway Biotechnology startups

EISMEA is an executive agency of the European Commission that implements European Union programs supporting innovation, small and medium-sized enterprises, and the Single Market. The agency manages the European Innovation Council and European Innovation Ecosystems programs under Horizon Europe. It also implements the SME component of the Single Market Programme and the Interregional Innovation Investments instrument. EISMEA provides funding and support for innovators, researchers, businesses, regions, and other organizations through grants, procurement, investment, and advisory programs. Its activities cover innovation development, SME competitiveness, entrepreneurship, market access, consumer policy, standardization, and interregional innovation. The agency also supports the implementation of EU policies and programs related to innovation ecosystems and economic development.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Biotechnology
  • Stage:Grant, Venture - Series Unknown, Seed
  • Geography: Spain, Italy, United Kingdom

Investor stats

  • Total investments: 3546
  • Round size: Seed $53k–$800k; Grant $54k–$2M; Venture - Series Unknown $573k–$2.6M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
  • BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
  • Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
Show all investments...

The Index Project
VC Fund · Copenhagen, Hovedstaden, Denmark · 1 investments in Norway Biotechnology startups

Design to improve life is about solving real problems, small and large, simple and complex, systemic and emerging and is a life-long pursuit. The Index Project is a call to action. Are you in?

Show more...

Investment focus

  • Industry: Chemical, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Series B
  • Geography: United States, Denmark, Chile

Investor stats

  • Total investments: 9
  • Round size: Seed $1.5M–$2M; Series A $1.1M–$3M
  • Lead/follow: 0% lead, 100% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Agribuddy — Management of agricultural support application "AGRIBUDDY".
  • CanopyLAB — CanopyLAB is an educational technology company located in Hvidovre, Greater Copenhagen, Denmark. We have built an AI-powered social learning platform for corporate training. Through personalization our platform enables all learners to realize their potential in a way that is fast, fun and future-proof. We call it "The Future of Learning-Delivered Today".We work on two verticals:1. The Canopy A social learning platform powered by AI A research-based social learning platform for developing competencies through individualized and adaptive learning experiences. It is designed with an integrated social network structure to enhance collaborative learning and built on strong Nordic learning principles.2. The LAB A learning community with provocative content Join our global learning community for youth. Take free courses, exchange ideas, gain new knowledge and practice competencies offered by 100 + pioneering NGOs in controversial and often neglected topics such as sexuality, sexual & reproductive rights, climate action, health, and the SDGs.CanopyLAB acquired Peruvian publishing startup Yopublico in April 2020.
  • Destácame — Destacame is the first behavior-based credit score in Latin America.
Show all investments...

NantBio
VC Fund · Culver City, California, United States · 1 investments in Norway Biotechnology startups

NantBio offers treatments by developing molecularly targeted drugs, based on the molecular profile of the patient’s tumor.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Seed
  • Geography: Norway

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Kure Cells — Kure Cells delivers innovative solutions in cell therapy, biotechnology, and clinical research to advance modern healthcare.
Show all investments...

DNB
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Biotechnology startups, 13 in the past 12 months

DNB is a financial services group that offers financial services through mobile, online banking, bank offices, and international offices. The Group provides a full range of financial services, including loans, savings, advisory services, insurance, and pension products for retail and corporate customers. The company’s personal banking products and services include savings and investment products. DNB offers its products and services to various sectors, including financial institutions, energy, manufacturing, healthcare, packaging, and forest products, shipping, offshore, and logistics, seafood, and telecom, media, and technology. They also distribute its products and services through its branches, in-store postal and banking outlets, and post office counters. DNB was founded in 1822 and is headquartered in Oslo, Norway.

Show more...

Investment focus

  • Industry: Renewable Energy, Energy, Oil and Gas
  • Stage:Post-IPO Debt, Debt Financing, Venture - Series Unknown
  • Geography: Norway, Sweden, United States

Investor stats

  • Total investments: 55
  • Round size: Post-IPO Debt $8.8M–$786M; Debt Financing $94M–$1.5B; Venture - Series Unknown $240k–$100M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Cadeler — Cadeler is an offshore services company that provides offshore wind installation and maintenance services. The company operates specialized vessels for transporting, installing, and servicing wind turbines and foundations in offshore environments, supporting the development of renewable energy infrastructure.
  • Ventura Offshore — Ventura Offshore is an oil and gas services company that specialises in drilling, project management, offshore services, and asset management within the oil and gas industry. The company ensures efficient and safe operations in challenging offshore environments. By delivering innovative solutions and maintaining the highest standards of quality andsafety, Ventura Offshore supports the energy sector in maximising productivity and resource management.
  • Clearway Energy Group — We're a leading independent clean power developer and operator with over 350 clean energy projects across America.
Show all investments...

Faber
VC Fund · Lisbon, Lisboa, Portugal · 1 investments in Norway Biotechnology startups, 7 in the past 12 months

Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively help founders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies. Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Portugal, Germany, United Kingdom

Investor stats

  • Total investments: 100
  • Round size: Seed $595k–$5.2M; Pre-Seed $121k–$3M; Series A $2.5M–$25M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely actively investing — fresh fund, raised $34M in 2024

Portfolio highlights

  • Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
  • Helix Robotics — We are building the first commercial soft manipulator
  • ATMOS Space Cargo — ATMOS Space Cargo develops and manufactures space capsules to return cargo from space, microgravity experiments, Commercial products to entire rocket stages.
Show all investments...

Bakken & Baeck
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Biotechnology startups

Since 2011, we have built products with some of the most ambitious companies out there. From defining the future of conversational AI with Sierra to building decentralised platforms with Coinbase.

Show more...

Investment focus

  • Industry: Chemical, Software, Life Science
  • Stage:Seed, Angel
  • Geography: Norway

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Versor — Versor develops software necessary for true autonomous drone flight both indoors and outdoors, enabling complete automation of industrial drone operations. They believe this level of automation requires superior localization, which is particularly difficult to achieve indoors and in GPS-denied areas. By removing the need for pilots, entire fleetsof drones may be supervised remotely, enabling true scalability of drone operations across various applications.
  • Iris.ai — Powerful Tools for Your Research. We have built a world-leading AI engine for scientific text understanding. Applied to literature reviews, data extraction, post-market surveillance or any other task involving thousands of documents like papers or patents, this engine will make your life a whole lot easier.
Show all investments...

PAACS Invest AS
VC Fund · 1 investments in Norway Biotechnology startups

PAACS Invest is a privately owned Norwegian investment firm that focuses on active investments in healthcare and technology with a focus on sustainability.

Show more...

Investment focus

  • Industry: Consulting, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Norway

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Hemispherian — Hemispherian is an innovative preclinical pharmaceutical company focused on developing a novel class of small molecule drugs. These drugs target the TET2 enzyme as an epigenetic therapy for particularly aggressive cancers.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Norselab
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Biotechnology startups

A startup studio situated in Oslo, built on and around the mobile and web development agency Norse Digital. Over the last few years, Norselab has created a strong portfolio of technology ventures built by the company's internal, world-class technology teams.

Show more...

Investment focus

  • Industry: Software, SaaS, Agriculture
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Norway, Switzerland, United States

Investor stats

  • Total investments: 21
  • Round size: Seed $500k–$6.3M; Series A $2.1M–$15M; Venture - Series Unknown $2.2M–$30M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Looping — Looping offers reuse as a service by substituting reusable transport packaging for single-use plastic products. It produces long-lasting and reusable transport wrapping for building modules, housing modules, and steel containers.
  • Beefutures — Rooted in the beekeeping legacy and driven by expert engineering, Beefutures delivers accessible nature-based solutions to power a more sustainable world.
  • Wanda — Wanda.space is a technology and logistics start-up delivering space as a service.
Show all investments...

Advent Life Sciences
VC Fund · London, England, United Kingdom · 1 investments in Norway Biotechnology startups

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences, principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 73
  • Round size: Series A $5.5M–$51M; Series B $21M–$97M; Venture - Series Unknown $7M–$104M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
  • Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

CoFounder
VC Fund · Trondheim, Sor-Trondelag, Norway · 1 investments in Norway Biotechnology startups

CoFounder is a management and investment company for technology companies with great growth potential. They are experienced entrepreneurs and business developers who provide management resources and early-stage capital. They work with spin-offs from both research and industrial environments, as well as standalone entrepreneurial companies.

Show more...

Investment focus

  • Industry: Industrial, Manufacturing, SaaS
  • Stage:Seed, Series A
  • Geography: Norway

Investor stats

  • Total investments: 10
  • Round size: Seed $956k–$2.3M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • AlumatIQ — AlumatIQ specializes in industrial robotics, automation, and digitalization in the aluminum industry. Their first product is robotic automation of the anode change process, with high accuracy, consistency, and speed. Improves health and safety conditions for operators in pot rooms and reduces emissions of HF and greenhouse gases.
  • Aviant — Delivering full-stack drone services that enables autonomous and on-demand transport of cargo.
  • Receipts — Receipts is a single set of APIs that connects cashier systems and banks, allowing for digital receipts, card identification, and retail value-added services.
Show all investments...

Fernando Lelo de Larrea H.
Angel · Mexico City, Distrito Federal, Mexico · 1 investments in Norway Biotechnology startups

As a relevant player in Mexico’s entrepreneurial ecosystem, Fernando is one of the most important and active early-stage investors in Mexico. He has extensive experience in operational and financial aspects of private equity, project finance, and managing growing businesses. He heads Rumbo Ventures, the leading climate tech fund for Latin America.Fernando co-founded ALLVP in 2012 and has since invested in over 24 service-oriented companies in sectors such as healthcare, financial services, mobility, and e-commerce. Additionally, he co-founded NUMA México (formerly Venture Institute), the leading startup accelerator platform, and Fondeadora, LATAM´s pioneer crowdfunding platform that was sold to Kickstarter in 2016.After his tenure as COO and CFO of Umbral Capital, Fernando became CEO of the real estate private equity fund where he was responsible for managing USD$ 50M in capital commitments, and continued as Chairman of the Board after founding ALLVP. Before Umbral Capital, Fernando was Deputy Director of the Division of Energy and Project Finance in Protego Asesores, now Evercore Partners.Fernando holds an MBA from Stanford GSB, an MA in Economics from London School of Economics, and a BA in Economics from ITAM. Fernando has been active in Alternative Assets for more than 20 years, the last ten as founding partner of ALLVP.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: Mexico, United States, Spain

Investor stats

  • Total investments: 34
  • Round size: Seed $155k–$1.5M; Series A $330k–$7.4M; Series B $4.7M–$21M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • CoreZero — Turning less into more
  • Thalasso — BLUE ECONOMY SARGASSUM MANAGEMENT
  • TRIBBU — Hoop Carpool is a SaaS Carpooling Platform for Companies, Universities and Citi-halls
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 1 investments in Norway Biotechnology startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 353
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
  • EnginZyme — Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at industrial scale.
Show all investments...

Innovestor
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Norway Biotechnology startups

Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Finland, Sweden, Denmark

Investor stats

  • Total investments: 87
  • Round size: Seed $478k–$4.5M; Pre-Seed $204k–$2M
  • Lead/follow: 59% lead, 41% follow
  • Last fund: May invest from a new fund soon — raised $35M in 2020

Portfolio highlights

  • Jaakko.com — Reinventing the housing market with no agents, more homes, and less fees.
  • Retailgrid — Retailgrid is an AI-powered retail workspace that enables pricing, merchandising, and commercial teams to analyze data, run simulations, and make decisions in real time. Combining a flexible spreadsheet-like interface with AI agents, RetailGrid replaces fragmented tools and manual workflows with a single system for pricing optimization, promotionplanning, and assortment decisions. The platform connects to product, sales, and competitor data, automatically generates insights, and allows teams to test scenarios and deploy decisions at scale. RetailGrid is built for data-driven retailers looking to move faster and operate with the efficiency of top-tier consulting, without the cost or complexity.
  • Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
Show all investments...

Arkin Bio Ventures
VC Fund · Herzliya, Tel Aviv, Israel · 1 investments in Norway Biotechnology startups

Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 24
  • Round size: Series A $11M–$125M; Series B $13M–$80M; Series C $19M–$182M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
  • Ambros Therapeutics — Ambros Therapeutics is a clinical-stage biotechnology company focused on the development of innovative and transformative medicines for diseases.
  • Reunion Neuroscience — Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions. The Company’s lead asset, RE104, is a proprietary, novel serotonergic psychedelic compound being developed as a potential fast-acting and durable antidepressant for patients suffering from postpartum depressionand other mental health conditions. Reunion is also developing the RE200 series, which includes compounds with the potential for more selective serotonin receptor activity and reduced psychoactivity for application in more chronic treatment paradigms and indications.
Show all investments...

Lekh Corp AS
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Biotechnology startups

Investment Company

Show more...

Investment focus

  • Industry: Software, Health Care, Life Science
  • Stage:Pre-Seed
  • Geography: Norway

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Aurora Analytica — Seven core decision engines and an orchestration layer working as one operating system for clinical development, from protocol optimization to study execution.
Show all investments...

Coalition for Epidemic Preparedness Innovations
VC Fund · Washington, District of Columbia, United States · 1 investments in Norway Biotechnology startups

CEPI is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Grant, Post-IPO Equity, Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 42
  • Round size: Grant $3.2M–$42M; Post-IPO Equity $2.5M–$145M
  • Lead/follow: 95% lead, 5% follow

Portfolio highlights

  • Hilleman Laboratories — Hilleman Laboratories a medical research organization is committed to developing high impact, affordable vaccines for people in the developing countries in an innovative and sustainable manner.
  • Minapharm Pharmaceuticals — MINAPHARM is constantly striving to provide innovative quality medicines and services to patients in developing countries so they, too, can get a timely benefit from the latest advances in pharmaceutical and biopharmaceutical research technologies. To achieve its mission and strategic goals, MINAPHARM exploits a robust research and developmentplatform combined with strategic multi-alliances involving industry players at the forefront of the latest pharmaceutical technologies, marketing and management techniques. This way has further enabled the establishment of specialized lines, embracing innovative and affordable products and services in the fields of Gastroenterology, Cardiology, Ophthalmology, Orthopedics, and Uro-gynaecology.
  • Serum Institute of India Pvt. Ltd. — Serum Institute of India Pvt. Ltd. is the vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at leastone vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 140 countries across the globe in their national immunization programs, saving millions of lives throughout the world.
Show all investments...

4BIO Capital
VC Fund · London, England, United Kingdom · 1 investments in Norway Biotechnology startups

4BIO Ventures is a London-based firm investing in venture capital and public equities in life sciences. They are focused on advanced therapies addressing high unmet medical and social needs.4BIO Capital Partners is an emerging asset manager focusing on private equity and venture capital in high growth and high return segments of biotech -biologics, gene and cell therapy and bioinformatics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 32
  • Round size: Seed $5M–$19M; Series A $24M–$94M; Series B $12M–$125M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $50M in 2019

Portfolio highlights

  • SparingVision — We are a genomic medicines company leading a step shift in how ocular diseases are treated. We are going beyond single gene correction therapies to deliver new treatments as quickly as possible to patients affected by Inherited Retinal Diseases (IRDs), regardless of genetic cause.
  • March Biosciences — Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity of
  • Cytospire Therapeutics — Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Teknoinvest
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Biotechnology startups

Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinavia according to track record of value created for their investors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A
  • Geography: Sweden, Norway, United States

Investor stats

  • Total investments: 25
  • Round size: Series A $1.2M–$12M; Series B $6M–$31M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: May invest from a new fund soon — raised $53M in 2002

Portfolio highlights

  • GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
  • SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
  • Sol Voltaics — Explore editorial solar guides, product analysis, comparisons and buying advice at SolVoltaics.com. Grab verified deals on Best Solar Brands.
Show all investments...

TeleVenture Management
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Biotechnology startups

Making Venture Happen. Televenture is one of the leading venture capital companies in Norway.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Biotechnology
  • Stage:Venture - Series Unknown, Seed
  • Geography: Norway, United States

Investor stats

  • Total investments: 26
  • Round size: Venture - Series Unknown $686k–$5.9M
  • Lead/follow: 65% lead, 35% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • CrayoNano — CrayoNano is a next generation semiconductor company. We specialize in nanotechnology that will enable a more sustainable and healthier life for tomorrow.
  • Genetic Analysis — Genetic Analysis AS (GA) has the goal of being a leader within the field of molecular diagnostics of diseases related to gut imbalances. By utilizing the DNA-based GA-map™ array technology, profiles of a patient’s gut microbiota is quickly generated and can be related to various health conditions. Genetic Analysis has developed a DNA-basedtechnology platform that allows for simultaneous analysis of a large number of similarities (but not identical) gene fragments in one reaction. The company’s focus is to utilize this technology platform to identify variations in the hundreds of different bacteria that exist in the gut (large and small intestine). The GA - map makes it possible, for the first time, to offer a diagnostic solution – including early detection - for many diseases that are affected by imbalances in the gut microbiota. Genetic Analysis will offer kits and services for a wide range of applications.
  • Stingray Marine Solutions — Stingray Marine Solutions is a Norwegian technology firm that produces a laser unit which, when lowered into salmon farming pens, kills sea lice. It is based on entrepreneur Esben Beck’s patented idea in 2010 for salmon louse removal using camera vision and laser. It all started with Esben Beck and a lathe in his basement in 1999. After more than10 years of deliveries to oil, gas and offshore companies, he decided to invest in his own products. He decided to found and develop his own salmon louse project, where design, production, software development, testing, and installation were carried out by using in-house resources.Stingray is based in Oslo, Norway.
Show all investments...

Surveyor Capital
VC Fund · Chicago, Illinois, United States · 1 investments in Norway Biotechnology startups, 11 in the past 12 months

Surveyor Capital is a fundamental equities business. Surveyor’s sector-aligned investment teams aim to generate alpha through a deep understanding of each company’s strategy, management teams, drivers of performance, and cyclical and secular industry trends over the medium and long term.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Post-IPO Equity, Series C
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 170
  • Round size: Series B $60M–$170M; Series C $60M–$226M; Post-IPO Equity $41M–$280M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Sol-Gel Technologies — Sol-Gel designs and delivers innovative dermatological drugs ranging from completely non-leachable to highly-controlled-release of unique formulations and compounds.
  • Perspective Therapeutics — Perspective Therapeutics is dedicated to finding the best ways to deliver remedies to patients and their medical needs, and they believe in a targeted, individualized approach to cancer treatment. We design treatments that are given exactly where the doctor needs them.
Show all investments...

Bioqube Ventures
VC Fund · Hasselt, Limburg, Belgium · 1 investments in Norway Biotechnology startups

Bioqube Ventures is a specialist life sciences venture capital fund investing in European biotech companies developing innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.Bioqube Venturesinvests through its independent fund “Bioqube Factory Fund I”: … an early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.… a fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. … a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.Medtech, healthtech and diagnostics are not part of our current investment scope.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: United States, France, Norway

Investor stats

  • Total investments: 18
  • Round size: Seed $5.7M–$24M; Series A $4M–$76M; Series B $23M–$108M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
  • Spica Therapeutics — Spica Therapeutics is a pioneering biotech company dedicated to transforming macrophage biology into breakthrough therapies for patients across multiple therapeutic areas. Leveraging its proprietary functional macrophage fingerprinting technology, Spica identifies and selectively targets disease-relevant macrophage sub
  • Primmune Therapeutics — Primmune Therapeutics is developing small molecule, orally-administered toll-like receptor 7 (TLR7) agonists to attack tumors and potentiate adaptive cancer immunotherapies, such as checkpoint inhibitors, to improve overall response rates and treatment durability.
Show all investments...

Innovations Kapital
VC Fund · Göteborg, Vastra Gotaland, Sweden · 1 investments in Norway Biotechnology startups

InnovationsKapital was founded in 1994 and is a leading independent venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in and Stockholm, Gothenburg and New York, is focused on investments within ICT and Healthcare & Life Sciences, dynamic sectors that are rapidly expanding and whereNordic research plays an important role. The capital is provided by highly reputable Swedish and international institutional investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series C
  • Geography: Sweden, Denmark, United States

Investor stats

  • Total investments: 19
  • Round size: Series B $5.6M–$30M; Series C $5.5M–$15M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Silecs — PiBond is an independent European maker of ultra-pure patterning, dielectric and optical materials for semiconductor, photonics and medical device clients.
  • SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
  • Action Pharma — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
Show all investments...

ERM Invest
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Biotechnology startups

Investment Company

Show more...

Investment focus

  • Industry: Software, Health Care, Life Science
  • Stage:Pre-Seed
  • Geography: Norway

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Aurora Analytica — Seven core decision engines and an orchestration layer working as one operating system for clinical development, from protocol optimization to study execution.
Show all investments...

Norwegian Research Council
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Biotechnology startups

The Norwegian Research Council is the government's central research advisor. In 2012, the Research Council researched with more than 7 billion. This represents about 30% of R & D funding in the state budget.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Information Technology
  • Stage:Grant, Seed, Venture - Series Unknown
  • Geography: Norway, Sweden

Investor stats

  • Total investments: 26
  • Round size: Grant $90k–$1.6M; Venture - Series Unknown $1.7M–$25M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Borregaard — Borregaard operates one of the world's most advanced and sustainable biorefineries.
  • Cartesian — Cartesian unlocks the power of thermal energy storage to help the world’s most energy-intensive sectors to boost energy efficiency and rapidly reduce their carbon footprint.
  • Lace Lithography — Lace is building the patterning technology that will power the next 100 years of semiconductor manufacturing.
Show all investments...

TD Veen
VC Fund · Stavanger, Rogaland, Norway · 1 investments in Norway Biotechnology startups

TD Veen is concerned with sustainable social development. Their contribution is to invest in companies and solutions that are good for both owners and society at large. The foundation of TD Veen is job satisfaction, creativity and a strong determination to invest in the very best people.At one stage they saw sense in targeting the investmentprofile, which also gave us a new perspective on the demand for returns and the role of investors. As a financial owner, they want to establish a healthy attitude toward results and returns. In companies where value is created over time.A differentiated portfolio is important to us. That is why they work with investments in new industries, such as e.g. health, or in parts of the world where they have not been before. Despite their Stavanger address, they want to invest outside of the petroleum sector.TD Veen has for many years supported the work of SOS Children’s Villages, including the project The Long Run, where they renovated old children’s villages in Romania and Lebanon. They have also contributed to starting up a separate pioneer project for foster families in Murmansk. Going ahead, they will to a greater degree also contribute to society at home, by building up a community of social entrepreneurs in Eiganesveien 95.

Show more...

Investment focus

  • Industry: Internet, Software, Information Technology
  • Stage:Seed, Venture - Series Unknown
  • Geography: Norway, United Kingdom, Germany

Investor stats

  • Total investments: 24
  • Round size: Seed $913k–$5.8M; Venture - Series Unknown $2M–$19M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Mobai — Provider of attack detection, image manipulation detection and authentication. Strong and successful research team on biometrics.
  • Dagens — Together with farmers and chefs, we co-create a transparent and resilient food system for the future. The farmers get a bigger part of the profit. Buyers get easy access to unique, biodiverse produce at competitive prices.
  • NoMy — Norwegian startup that researches and develops sustainable material and food solutions using mycelium
Show all investments...

Gezina
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Biotechnology startups

Gezina

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Clinical Trials
  • Geography: Norway

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investments in Norway Biotechnology startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 141
  • Round size: Series A $6M–$73M; Series B $12M–$92M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $179M in 2024

Portfolio highlights

  • Neobiomics — Advancing neonatal care through evidence-based clinical nutrition.
  • AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Qomel
VC Fund · Riyadh, Ar Riyad, Saudi Arabia · 1 investments in Norway Biotechnology startups

Qomel Company is a healthcare and pharmaceutical services company that offers medical, diagnostic, and product distribution services. It operates ophthalmology, dental, wound care, and general medical services, while distributing pharmaceuticals and medical devices through warehouses and sales offices.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Seed
  • Geography: Norway

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Kure Cells — Kure Cells delivers innovative solutions in cell therapy, biotechnology, and clinical research to advance modern healthcare.
Show all investments...

Dynamk Capital
VC Fund · New York, New York, United States · 1 investments in Norway Biotechnology startups

Dynamk Capital is a New York headquartered growth equity and venture capital firm investing in life science industrials: tools, technologies and services that are critical for the discovery, development and production of life-saving therapies. Venture capital for Life Science tools.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: United States, Canada, Norway

Investor stats

  • Total investments: 20
  • Lead/follow: no public data

Portfolio highlights

  • CellFE — We transform the way cell therapies are manufactured to enable affordable advanced treatments for all.
  • Lucid Scientific — Lucid Scientific is the maker of Resipher - the world's first handheld cell culture monitor to measure real-time oxygen consumption from inside an incubator.
  • Vernal Biosciences — Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.
Show all investments...

Advent Venture Partners
VC Fund · London, England, United Kingdom · 1 investments in Norway Biotechnology startups

Advent Venture Partners is one of Europe's most successful growth and venture capital investors in market-leading tech and life sciences businesses. They have designed their strategy, teams and funds so they can focus on backing a select few companies. They pride their selves on establishing true partnerships with entrepreneurs in order tobuild valuable businesses together.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 91
  • Round size: Series A $6.6M–$26M; Series B $7M–$50M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $25M in 2019

Portfolio highlights

  • Wiz — Organizations of all sizes and industries use Wiz to rapidly identify and remove the most critical risks in AWS, Azure, GCP, and Kubernetes so they can build faster and more securely.
  • OpenCloud — Our cloud native software solutions dramatically improve operator business models and help quickly create new revenue-generating services.
  • Acutus Medical — Acutus Medical develops medical technologies to treat complex cardiac arrhythmia. The company's platform displays the heart’s true activation pattern, turning the chaos of a complex arrhythmia into a clear vision for electrophysiologists.Acutus Medical is a privately funded company founded in 2011 and based in Carlsbad, California. Itsproducts are co-developed in the U.S. and Europe with an exceptional team of medical scientists, biomedical engineers, and other professionals.It was founded in 2011 and headquartered in Carlsbad, California.
Show all investments...

Nordic Impact
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Biotechnology startups

Nordic Impact invests in, supports, and builds businesses and funds based around technology. The company's goal is to make impact investing mainstream and mobilize all business and capital towards solving the big problems in the world while making great financial returns.

Show more...

Investment focus

  • Industry: Chemical, Life Science, Visual Search
  • Stage:Seed
  • Geography: Norway

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Iris.ai — Powerful Tools for Your Research. We have built a world-leading AI engine for scientific text understanding. Applied to literature reviews, data extraction, post-market surveillance or any other task involving thousands of documents like papers or patents, this engine will make your life a whole lot easier.
Show all investments...

Project Sandwater
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Biotechnology startups

Project Sandwater is a fresh take on venture investments within the Nordics and beyond.

Show more...

Investment focus

  • Industry: Medical, Consulting, Life Science
  • Stage:Series A
  • Geography: Norway, The Netherlands

Investor stats

  • Total investments: 2
  • Round size: Series A $12M–$20M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Delft IMP — Delft IMP (Intensified Materials Production) commercializes nanostructuring of particles using atomic and molecular layer deposition (ALD and MLD), based on the patented and publicized IP and know-how developed within the Product & Process Engineering (PPE) group at Delft University of Technology. Following various feasibility projects betweenindustry and university, Delft IMP was initiated end 2014 to truly commercialize the technology.
  • Cytovation — Cytovation AS is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway.
Show all investments...

SR One
VC Fund · Cambridge, Massachusetts, United States · 1 investments in Norway Biotechnology startups

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 203
  • Round size: Series A $6M–$100M; Series B $15M–$114M; Series C $22M–$175M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely actively investing — fresh fund, raised $237M in 2025

Portfolio highlights

  • CalciMedica — CalciMedica is a clinical-stage biopharmaceutical company advancing CRAC channel inhibitors for pulmonary hypertension and acute pancreatitis.
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • Korsana Biosciences — Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases. The company focuses on shuttled monoclonal antibodies that cross the blood-brain barrier to reach central nervous system targets. Its lead program, KRSA-028, is an investigational anti-amyloid beta antibody for Alzheimer’s disease that uses a transferrinreceptor-based shuttle and Fc engineering to improve brain delivery and dosing. Korsana is also advancing additional THETA-based programs for undisclosed neurodegenerative indications.
Show all investments...

H2O Holding AS
VC Fund · 1 investments in Norway Biotechnology startups

Investment

Show more...

Investment focus

  • Industry: Software, Health Care, Life Science
  • Stage:Pre-Seed
  • Geography: Norway

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Aurora Analytica — Seven core decision engines and an orchestration layer working as one operating system for clinical development, from protocol optimization to study execution.
Show all investments...

Patrick Pichette
Angel · London, England, United Kingdom · 1 investments in Norway Biotechnology startups

Patrick Pichette is based out of London, England, and is the Partner of Inovia Capital and also Board Member of Cohere. Patrick Pichette previously worked at Twitter as a Board of Directors. Patrick Pichette attended the University of Oxford.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 27
  • Round size: Seed $913k–$10M; Series A $10M–$95M; Series B $15M–$95M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Mobai — Provider of attack detection, image manipulation detection and authentication. Strong and successful research team on biometrics.
  • Kaedim — AI-powered 3D asset creation service delivering fast, production-ready 3D assets. Scale 3D pipelines without hiring, accelerate 3D game art production, and reduce 3D asset costs by up to 90%.
  • Clove — Building a financial institution for how we live and work today.
Show all investments...

World Wildlife Fund
VC Fund · Washington, District of Columbia, United States · 1 investments in Norway Biotechnology startups

World Wildlife Fund - The leading organization in wildlife conservation and endangered species. Learn how you can help WWF make a difference.

Show more...

Investment focus

  • Industry: Seafood, Aquaculture, Food Processing
  • Stage:Seed, Series A
  • Geography: Canada, Norway, Faroe Islands

Investor stats

  • Total investments: 11
  • Round size: Seed $1.5M–$4.7M; Series A $2.9M–$6.2M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • SeaForester — Restoring the forgotten forests in our ocean.
  • Cascadia Seaweed — Powered by the Sea. Proven on the Farm. Explore Cascadia Seaweed's portfolio of regenerative solutions, from kelp-based agricultural biostimulants to AI-powered biodiversity monitoring with OceanNexus. Through Cascadia Seaweed and Cascadia Nature-based Solutions, we're helping build healthier farms
  • Ocean Rainforest — Ocean Rainforest offer a collection of premium fully-traceable seaweed products, mostly for food and cosmetic producers.The company has developed a structural system for macroalgae cultivation in open oceans and related on-shore processes for bringing the seaweed into a storage stable condition.
Show all investments...

Protonic Partners
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Biotechnology startups

Protonic Partners is an investment firm.

Show more...

Investment focus

  • Industry: SaaS, Biometrics, Information Services
  • Stage:Seed
  • Geography: Norway

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Mobai — Provider of attack detection, image manipulation detection and authentication. Strong and successful research team on biometrics.
Show all investments...

Biotechnology Investor funding in Norway at a glance

Stats across 128 deals from 152 investors.

152
investors
in Norway Biotechnology startups
128
deals
in Norway Biotechnology startups
$2.7M
median round
in Norway Biotechnology startups
38%
lead investors
lead at least one round
22%
Grant
most common funding stage
84/16
VC / Angel
share of investor count

Access all 152 investors in Norway Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Investors in Norway investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 152 investors investing in Norway Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists